CTRI/2009/091/001079
Completed
Phase 3
COMPARATIVE ASSESSMENT OF THE EFFICACY, SAFETY AND TOLERABILITY OF SERTACONAZOLE 2% plus ZINC PYRITHIONE 1% SHAMPOO vs KETOCONAZOLE 2% SHAMPOO IN ADULT PATIENTS WITH DANDRAFF/ SEBORRHEIC DERMATITIS OF THE SCALP
Glenmark Pharmaceuticals Ltd. Mumbai, India0 sites200 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Glenmark Pharmaceuticals Ltd. Mumbai, India
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Males and non\-pregnant females (with negative \&\#61538;\-human chorionic gonadotropin test). Female patients on adequate contraceptive control.
- •Age: 18 to 70 years
- •All newly diagnosed cases of Mild, Moderate or Severe Dandruff and /or Seborrheic dermatitis of the scalp
- •Patient willing to comply with study procedures and requirements
Exclusion Criteria
- •Pregnant and nursing women
- •Patients hypersensitive to any study medications and ingredients
- •Psoriasis of scalp
- •Atopic dermatitis
- •Tinea capitis
- •Parkinson?s disease, epilepsy, facial nerve paresis, spinal cord disease
- •Shoulder length or longer hair
- •Topical treatment of the scalp with other antifungal medication or with corticosteroids in the last 2weeks before start of washout period.
- •Systemic use of retinoids, erythromycin, tetracycline or any of its derivatives, trimethoprim/sulfamethoxazole or metronidazole within 28 days before start of washout period
- •Uncontrolled diabetes
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
A clinical trial to study the effects of two different formulations of diacerein in patients with osteoarthritis of the knee.CTRI/2009/091/000300Glenmark Pharmaceuticals Ltd210
Completed
Phase 3
A clinical trial to study the effects of a fixed dose combination of two drugs Diacerein + Aceclofenac and aceclofenac on patients with osteoarthritisCTRI/2010/091/000081Glenmark Pharmaceuticals Ltd200
Completed
Phase 4
Comparison of effect,safety and cost of sertaconazole cream versus luliconazole cream in patients with dermatophytosesHealth Condition 1: null- DERMATOPHYTOSES PATIENTSHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissueCTRI/2017/11/010418Government Medical College59
Completed
Phase 4
A clinical trial to compare the evaluation of efficacy, safety and tolerability of three expectorants in the treatment of productive cough associated with acute bronchitis, AECB, pneumonia and asthmatic bronchitis in Indian populatioCTRI/2009/091/000112Glenmark Pharmaceuticals LtdBD Sawant Marg, Chakala, Off. Western Express Highway, Andheri (E), Mumbai 400 099354
Completed
Phase 4
A COMPARATIVE STUDY TO EVALUATE EFFICACY AND SAFETY BETWEEN GABAPENTIN, PREGABALIN AND DULOXETINE IN PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHYHealth Condition 1: null- Peripheral diabetic neuropathyCTRI/2009/091/001058Research society for the study of diabetes in India RSSDI152